Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ortho-McNeil calls off Topamax 100mg tablets
The reason behind the recalling of drugs is related to the complains of uncharacteristic odor associated with the medication caused by trace amounts of TBA (2,4,6 tribromoanisole). TBA
The reason behind the recalling of drugs is related to the complains of uncharacteristic odor associated with the medication caused by trace amounts of TBA (2,4,6 tribromoanisole). TBA
ERT offers centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes ePRO in multiple modalities across all phases of clinical research.
Under the contract, Trius will receive up to $3m over three years in support of its development efforts. The current contract aims to create antibiotics that kill bacteria
The transaction will be funded by a combination of cash and existing debt financing. Hikma CEO Said Darwazah said through this strategic partnership, Hikma and Unimark will collaborate
Tofacitinib is a novel, oral Janus kinase (JAK) inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for RA. ORAL Scan is an ongoing two-year
The Phase 2 trial is designed to investigate the efficacy and safety of SB1518 in patients with advanced lymphoid malignancies. In the trial, three patients demonstrated partial response
The QBC STAR measures nine important CBC hematological parameters from venous or capillary blood samples: hematocrit, hemoglobin, mean corpuscular hemoglobin concentration (MCHC), platelet count, white blood cell count,
The new patent entitled, ‘Oligonucleotides for Treatment of Prostate and other Cancers,’ includes coverage for antisense and siRNA compositions that reduce the amount of active Heat Shock Protein
The transaction represents the second successful licensing agreement of a technology jointly developed between a CDRD-affiliated institution and CDRD, and the first between BCCA and CDRD. Irinophore C
TransVax is used for the prevention of reactivation of latent cytomegalovirus (CMV) or introduction of CMV through donor cells or tissues in transplant recipients. The vaccine is formulated